Sitagliptin added to ongoing metformin therapy provides sustained glycemic control over 54 weeks, with a low incidence of hypoglycemia and with weight loss (Abstract 0523-P)
Br J Cancer 75 : 251257 D'Ambrosio C, Ferber A, Resnicoff M, Baserga R (1996) A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis
A 2025 orthopaedic sports medicine systematic review describes increasing use despite lack of FDA approval and bans in sport, and emphasizes that the evidence base is dominated by preclinical studies with limited high-quality human data
Several modes of ROS-mediated protein oxidation are reported, including metal-catalyzed oxidation, oxidation-induced cleavage, amino acid oxidation, and the conjugation of lipid peroxidation products (43)
Payers are still implementing some strict policies when it comes to reimbursing treatment with oral obesity drugs